Skip to main content
  • Home
  • Articles
    • Archive from 2022 July
    • Archive 1960 to 2022 June
    • Accepted Articles
    • Published Ahead-of-Print
    • Supplement
  • About
  • For Authors
  • Podcasts

The patella as an unusual site of renal cell carcinoma metastasis

< Back to Listing

Share this Article

Singapore Med J 2007; 48(12): e314-e319
The patella as an unusual site of renal cell carcinoma metastasis

  • Abstract
  • PDF

Lim CT, Wong AS, Chuah BYS, Putti TC, Stanley AJ, Nathan SS
Correspondence: Dr Saminathan S Nathan, dosssn@nus.edu.sg

ABSTRACT
We report a rare case of renal cell carcinoma with metastasis to the patella in a 49-year-old man, who presented with seven months of left knee pain after a fall. Only two similar cases have been reported. Patellar metastasis is rare because it has a relatively poor blood supply and microemboli would have been sieved out by the pulmonary circulation. Patellectomy is the usual treatment for such cases. We suspect that the preferential metastasis in our patient is a result of tropism. Our treatment for this patient is unique. We opted for a patella-preserving operation involving the use of cryotherapy, as this treatment modality preserved the quality of life. An opportunistic biopsy one year later confirmed the absence of active disease within the patella. This case uniquely provides human in vivo histological confirmation that an intralesional procedure with local and systemic adjuvant therapy effectively controls local disease.

Keywords: cryotherapy, patella, patellar metastasis, renal cell carcinoma, tropism
Singapore Med J 2007; 48(12): e314–e319

http://smj.org.sg/sites/default/files/4812/4812cr3.pdf
×

Around the Site

Home

About SMJ

For Reviewers

Sign Up for Alerts

Issues

Current Issue

All Issues

Online First

Supplement

CME

For Authors

Instructions for Authors

Submit Manuscript


Follow us on:
        

More Links

Contact Us

Copyright

Advertise

SMJ Forms

Privacy Policy

SMA Home

Copyright 2021. Singapore Medical Association. All Rights Reserved.